Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000795689 | SCV000935159 | likely benign | Nemaline myopathy 2 | 2023-09-26 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003133608 | SCV003810154 | uncertain significance | not provided | 2019-05-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003307436 | SCV004000029 | uncertain significance | Inborn genetic diseases | 2023-05-18 | criteria provided, single submitter | clinical testing | The c.19594C>T (p.R6532C) alteration is located in exon 148 (coding exon 146) of the NEB gene. This alteration results from a C to T substitution at nucleotide position 19594, causing the arginine (R) at amino acid position 6532 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV000795689 | SCV001459157 | uncertain significance | Nemaline myopathy 2 | 2020-09-16 | no assertion criteria provided | clinical testing |